Free fatty acid metabolic profile and biomarkers of isolated post-challenge diabetes and type 2 diabetes mellitus based on GC-MS and multivariate statistical analysis

被引:102
|
作者
Liu, Liyan [1 ]
Li, Ying [1 ]
Guan, Chunmei [1 ]
Li, Kang [1 ]
Wang, Cheng [1 ]
Feng, Rennan [1 ]
Sun, Changhao [1 ]
机构
[1] Harbin Med Univ, Dept Nutr & Food Hyg, Publ Hlth Coll, Harbin 150086, Peoples R China
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2010年 / 878卷 / 28期
关键词
Free fatty acid; Biomarker; Isolated post-challenge diabetes; Type 2 diabetes mellitus; Gas chromatography-mass spectrometry; CARDIOVASCULAR-DISEASE; RISK; HYPERGLYCEMIA; NUTRITION; GLUCOSE; HEALTH;
D O I
10.1016/j.jchromb.2010.08.035
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Isolated post-challenge diabetes (IPD, 2h-PG >= 11.1 mmol/L and FPG < 7.0 mmol/L) is often ignored in screening for diabetes by fasting plasma glucose (FPG) levels. The aim of this study was to investigate the metabolic profiles of serum free fatty acids (FFAs) and to identify biomarkers that can be used to distinguish patients with IPD from those with type 2 diabetes mellitus (T2DM) or healthy control individuals. FFA profiles of the subjects were investigated using gas chromatography-mass spectrometry (GC-MS). Principal component analysis (PCA) and partial least squares-discriminant analysis (PLS-DA) were used for classification and prediction among the three groups. The predictive correct rates were 92.86% for IPD and healthy control individuals and 90.70% for T2DM and healthy control individuals, indicating that PLS-DA could satisfactorily distinguish IPD individuals from healthy controls and those with T2DM. Finally, palmitic acid, stearic acid, oleic acid, linoleic acid and a-linolenic acid were identified as potential biomarkers for distinguishing IPD from healthy control and T2DM individuals. These potential biomarkers might be helpful for diagnosis and characterization of diabetes. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:2817 / 2825
页数:9
相关论文
共 46 条
  • [21] Analysis of Intestinal Short-Chain Fatty Acid Metabolism Profile After Probiotics and GLP-1 Treatment for Type 2 Diabetes Mellitus
    Min, Qiuxia
    Wang, Yan
    Jin, TaiCheng
    Zhu, Lei
    Wu, XianYan
    Li, YiKun
    Wang, YanJiao
    Xu, Ning
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [22] Plasma fatty acid metabolic profile coupled with uncorrelated linear discriminant analysis to diagnose and biomarker screening of type 2 diabetes and type 2 diabetic coronary heart diseases
    Lun Zhao Yi
    Da Lin Yuan
    Zhi Hong Che
    Yi Zeng Liang
    Zhi Guang Zhou
    Hai Yan Gao
    Ya Min Wang
    Metabolomics, 2008, 4 : 30 - 38
  • [23] Plasma fatty acid metabolic profile coupled with uncorrelated linear discriminant analysis to diagnose and biomarker screening of type 2 diabetes and type 2 diabetic coronary heart diseases
    Yi, Lun Zhao
    Yuan, Da Lin
    Che, Zhi Hong
    Liang, Yi Zeng
    Zhou, Zhi Guang
    Gao, Hai Yan
    Wang, Ya Min
    METABOLOMICS, 2008, 4 (01) : 30 - 38
  • [24] Omega-6 Fatty Acid Biomarkers and Incident Type 2 Diabetes: A Pooled Analysis of 20 Cohort Studies
    Wu, Jason H.
    Marklund, Matti
    Imamura, Fumiaki
    Tintle, Nathan
    Korat, Andres V. Ardisson
    de Goede, Janette
    Zhou, Xia
    Yang, Wei-Sin
    Otto, Marcia C. de Oliveira
    Kroger, Janine
    Qureshi, Waqas
    Virtanen, Jyrki K.
    Bassett, Julie
    Frazier-Wood, Alexis C.
    Lankinen, Maria
    Murphy, Rachel A.
    Rajaobelina, Kalina
    Lemaitre, Rozenn N.
    Micha, Renata
    Mozaffarian, Dariush
    CIRCULATION, 2017, 135
  • [25] Lipidomics based on UHPLC/Q-TOF-MS to characterize lipid metabolic profiling in patients with newly diagnosed type 2 diabetes mellitus with dyslipidemia
    Zhong, Xunlong
    Xiao, Chang
    Wang, Ruolun
    Deng, Yunfeng
    Du, Tao
    Li, Wangen
    Zhong, Yanmei
    Tan, Yongzhen
    HELIYON, 2024, 10 (04)
  • [26] Screening for potential serum-based proteomic biomarkers for human type 2 diabetes mellitus using MALDI-TOF MS
    Meng, Qiutao
    Ge, Siqi
    Yan, Wenhua
    Li, Ruisheng
    Dou, Jingtao
    Wang, Haibing
    Wang, Baoan
    Ma, Qingwei
    Zhou, Yong
    Song, Manshu
    Yu, Xinwei
    Wang, Hao
    Yang, Xinghua
    Liu, Fen
    Alzain, Mohamed Ali
    Yan, Yuxiang
    Zhang, Ling
    Wu, Lijuan
    Zhao, Feifei
    He, Yan
    Guo, Xiuhua
    Chen, Feng
    Xu, Weizhuo
    Garcia, Monique
    Menon, Desmond
    Wang, Youxin
    Mu, Yiming
    Wang, Wei
    PROTEOMICS CLINICAL APPLICATIONS, 2017, 11 (3-4)
  • [27] Effects of coenzyme Q10 on cardiovascular and metabolic biomarkers in overweight and obese patients with type 2 diabetes mellitus: a pooled analysis
    Huang, Haohai
    Chi, Honggang
    Liao, Dan
    Zou, Ying
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGET & THERAPY, 2018, 11 : 875 - 886
  • [28] Large-Scale Proteomic Analysis of Patients with Type 2 Diabetes Mellitus and Atherosclerosis Using a Label-Free LC-MS/MS Approach
    Surmen, Mustafa Gani
    Bozkaya, Tijen Alkan
    Ates, M. Sanser
    Surmen, Saime
    Cakici, Cagri
    Pence, Sadrettin
    Emekli, Nesrin
    EXPERIMED, 2023, 13 (01): : 26 - 38
  • [29] Relation of Plasma Fatty Acid Binding Proteins 4 and 5 With the Metabolic Syndrome, Inflammation and Coronary Calcium in Patients With Type-2 Diabetes Mellitus
    Bagheri, Roshanak
    Qasim, Atif N.
    Mehta, Nehal N.
    Terembula, Karen
    Kapoor, Shiv
    Braunstein, Seth
    Schutta, Mark
    Iqbal, Nayyar
    Lehrke, Michael
    Reilly, Muredach P.
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (08) : 1118 - 1123
  • [30] Trans Fatty Acid Biomarkers and Incident Type 2 Diabetes: Pooled Analysis of 12 Prospective Cohort Studies in the Fatty Acids and Outcomes Research Consortium (FORCE)
    Lai, Heidi T. M.
    Imamura, Fumiaki
    Korat, Andres V. Ardisson
    Murphy, Rachel A.
    Tintle, Nathan
    Bassett, Julie K.
    Chen, Jiaying
    Kroeger, Janine
    Chien, Kuo-Liong
    Senn, Mackenzie
    Wood, Alexis C.
    Forouhi, Nita G.
    Schulze, Matthias B.
    Harris, William S.
    Vasan, Ramachandran S.
    Hu, Frank
    Giles, Graham G.
    Hodge, Allison
    Djousse, Luc
    Brouwer, Ingeborg A.
    Qian, Frank
    Sun, Qi
    Wu, Jason H. Y.
    Marklund, Matti
    Lemaitre, Rozenn N.
    Siscovick, David S.
    Fretts, Amanda M.
    Shadyab, Aladdin H.
    Manson, JoAnn E.
    Howard, Barbara, V
    Robinson, Jennifer G.
    Wallace, Robert B.
    Wareham, Nick J.
    Chen, Yii-Der Ida
    Rotter, Jerome, I
    Tsai, Michael Y.
    Micha, Renata
    Mozaffarian, Dariush
    DIABETES CARE, 2022, 45 (04) : 854 - 863